Skip to main content

The Global Viral Inactivation market is expected to reach $1,209.17 million by 2026 growing at a CAGR of 14.2% from 2018 to 2026.

The key vendors mentioned are Merck KGAA, Cerus Corporation, Thermo Fisher Scientific Inc., Sartorius AG, Danaher Corporation, Texcell, Inc, SGS SA, Invitrogen Corp., General Electric Co., Rad Source Technologies, Qiagen NV, ZeptoMetrix Corp., and BioReliance.

Hyderabad, India - October 9, 2019 /MarketersMedia/

Viral inactivation is a dynamic component of the process of viral clearance that is compulsory for any phase of drug development. Regulatory officials such as the FDA have deepened the demand for viral inactivation in numerous applications including stem cell products, therapeutics, blood & blood products, tissue & tissue products, cell & gene treatment and vaccines. Factors such as increasing government support for pharmaceutical and biotechnology industries, an increase in the number of drug launches & approvals and rising investment in the life sciences sector are driving the market growth. Though, high cost of biologics and biosimilar products development & manufacturing restrain the market growth.

Access the complete report at: https://www.syngeneresearch.com/global-viral-inactivation-market-analysis-2019/

Based on the product, Kits and reagents are expected to have a lucrative growth during the forecast period due to their continuous usage by pharmaceutical and biopharmaceutical companies. With an increase in the number of pharmaceutical and biopharmaceutical companies and the rise in R&D spending for the purpose of new drug development, the usage of kits and reagents has increased tremendously.

Make an inquiry at: https://www.syngeneresearch.com/global-viral-inactivation-market-analysis-2019/

Products Covered:
• Services
• Viral Inactivation Systems and Accessories
• Kits and Reagents

Methods Covered:
• Pasteurization
• Solvent Detergent Method
• Other Methods

Applications Covered:
• Blood and Blood Products
• Tissues and Tissue Products
• Vaccines and Therapeutics
• Stem Cell Products
• Cellular and Gene Therapy Products

End Users Covered:
• Pharmaceutical and Biotechnology Companies
• Academic Research Institutes
• Contract Research Organizations
• Blood Banks and Hospitals

Regions Covered:
• North America
• Europe
• Asia Pacific
• South America
• Middle East & Africa

Learn more about Syngeneresearch here: https://www.syngeneresearch.com/about-syngene-research/

Key Questions Answered in this Report:
• How this market evolved since the year 2016
• Market size estimations, forecasts and CAGR for all the segments presented in the scope
• Key Market Developments and financials of the key players
• Opportunity Analysis for the new entrants
• SWOT Analysis of the key players
• Fastest growing markets analysed during the forecast period

Contact Info:
Name: Sadhana Shukla
Email: Send Email
Organization: Syngene Market Research Reports
Website: https://www.syngeneresearch.com/

Source URL: https://marketersmedia.com/the-global-viral-inactivation-market-is-expected-to-reach-120917-million-by-2026-growing-at-a-cagr-of-142-from-2018-to-2026/88926739

Source: MarketersMedia

Release ID: 88926739

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.